Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China

Diabetes Care

Volumn 33, Issue 3, 2010, Pages 545-550

  Zhou, Xianghai ^a,b,c   Pang, Zengchang ^d   Gao, Weiguo ^a,e   Wang, Shaojie ^d   Zhang, Lei ^a,e   Ning, Feng ^a   Qiao, Qing ^a,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c PEKING UNIVERSITY   (China)

^d Qingdao Center for Disease Control and Prevention   (China)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CHINA; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FASTING CAPILLARY BLOOD GLUCOSE TEST; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADULT; AGED; BLOOD GLUCOSE; CAPILLARIES; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIAGNOSTIC TECHNIQUES, ENDOCRINE; EARLY DIAGNOSIS; EFFICIENCY; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE;

EID: 77649252158     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1410     Document Type: Article

References (25)

1. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999 (WHO/NCD/NCS/99.2)
2. Eschwège E, Charles MA, Simon D, et al. Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. Diabetes Care 2001; 24:1941-1944
3. Drzewoski J, Czupryniak L. Concordance between fasting and 2-h post-glucose challenge criteria for the diagnosis of diabetes mellitus and glucose intolerance in high risk individuals. Diabet Med 2001; 18:29-31
4. Toscano CM, Duncan BB, Mengue SS, et al. Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study. BMC Health Serv Res 2008;8:189
5. Spijkerman AM, Adriaanse MC, Dekker JM, et al. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002;25:1784-1789
6. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30:2399-2400
7. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
8. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419
9. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007;96:644-647
10. Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23:187-191
11. Colagiuri S, Hussain Z, Zimmet P, et al. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. Diabetes Care 2004;27:367-371
12. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007;30:2233-2235
13. Ko GT, Chan JC, Yeung VT, et al. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998; 21:1221-1225
14. Saydah SH, Byrd-Holt D, Harris MI. Projected impact of implementing the results of the Diabetes Prevention Program in the U.S. population. Diabetes Care 2002;25: 1940-1945
15. Mannucci E, Ognibene A, Sposato I, et al. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2003;40:181-186
16. Bortheiry AL, Malerbi DA, Franco LJ. The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT. Diabetes Care 1994; 17:1269-1272
17. Herdzik E, Safranow K, Ciechanowski K. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test. Acta Diabetol 2002;39:15-22
18. Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413-420
19. Nakanishi S, Yamada M, Hattori N, et al. Relationship between HbA1c and mortality in a Japanese population. Diabetologia 2005;48:230-234
20. Qiao Q, Dekker JM, de Vegt F, et al. Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c. J Clin Epidemiol 2004;57:590-596
21. Barr EL, Boyko EJ, Zimmet PZ, et al. Continuous relationships between nondiabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009;52:415-424
22. Meigs JB, Nathan DM, D'Agostino RB Sr, et al. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-1850
23. Ning F, Pang ZC, Dong YH, et al. Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China. Diabet Med 2009;26:855-863
24. Gao WG, Dong YH, Pang ZC, et al. Increasing trend in the prevalence of type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China. Diabet Med 2009;26: 1220-1229
25. Zeng YT, Huang SZ. Disorders of haemoglobin in China. J Med Genet 1987;24: 578-583